Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 3,280 | 4,530 | 19,150 |
| Marketable Securities | N/A | 680 | 6,350 | 4,210 |
| Receivables | N/A | 820 | 970 | 26,050 |
| Inventories | N/A | 960 | 880 | 0 |
| Other current assets | 0 | 80 | 200 | 3,830 |
| TOTAL | $N/A | $5,820 | $12,930 | $53,240 |
| Non-Current Assets | ||||
| PPE Net | N/A | 990 | 940 | 6,100 |
| Other Non-Current Assets | 0 | 2,360 | 1,340 | 750 |
| TOTAL | $N/A | $3,350 | $2,280 | $6,850 |
| Total Assets | $N/A | $9,180 | $15,230 | $60,120 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 1,320 | 1,760 | 7,910 |
| Accrued Expenses | N/A | 0 | 0 | 26,960 |
| Other current liabilities | N/A | 140 | 260 | 19,300 |
| TOTAL | $N/A | $1,530 | $2,070 | $54,190 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $90 | $82 | $96 |
| Total Liabilities | $N/A | $1,630 | $2,160 | $54,290 |
| Shareholders' Equity | ||||
| Common Shares | N/A | 42,280 | 29,280 | 70 |
| Retained earnings | N/A | -35,560 | -27,170 | -137,900 |
| Other shareholders' equity | 0 | 240 | 10,960 | -990 |
| TOTAL | $N/A | $7,550 | $13,070 | $5,820 |
| Total Liabilities And Equity | $0 | $9,180 | $15,230 | $60,110 |